Free corona tests Pharmacies want to reduce supply

Status: 06/20/2021 07:22 a.m.

In view of falling demand and less money from the federal government, many pharmacies want to reduce their range of corona rapid tests. The implementation is no longer economical. Due to the falling demand for corona tests, Germany’s pharmacies want to limit their range. Since the number of fully vaccinated is increasing and infection protection rules have been relaxed, the need for tests is decreasing, said a spokesman for the Abda pharmacists’ association. He also pointed out that the federal government pays less than before. “This means that it is no longer economical to carry out the tests for a number of pharmacies.” The test offer will therefore probably get smaller step by step. Alongside private companies and state institutions, pharmacies are among the most important test center operators. According to Abda estimates, around 20 to 25 percent of pharmacies offer so-called citizen tests – that is, rapid tests that are free for consumers and paid for by the federal government.

Less money for tests

Originally, the pharmacies, like all other providers, received up to 18 euros per antigen test carried out, now the federal government only pays up to 12.50 euros. In the corona pandemic, spring tests were key to ensuring that people with a negative result could visit restaurants or shops.

However, the number of infections is now so low that loosening takes effect and a visit to a restaurant or shopping is permitted even without a test result. In addition, fully vaccinated people are exempt from test requirements.

Fewer and fewer rapid tests

Figures from the NRW Ministry of Health show how much demand is falling. Last Thursday there were 306,000 rapid antigen tests via the test centers in the state. Of those, 216 were positive – a percentage of 0.07 percent. A week earlier there were 498,000 tests in one day (positive: 0.08 percent); a month ago it was 594,000 (positive: 0.23 percent). The number of test sites in North Rhine-Westphalia was recently stable at 9236 – it will probably decrease in the future.

The Association of the Diagnostics Industry, which represents manufacturers of tests, assumes that the demand for antigen tests in the test centers will drop significantly in the summer. The manufacturers will “of course adjust to a permanently falling demand,” said an association spokeswoman. But they are working on tests that could detect both influenza and coronavirus disease. Such tests could help in the fall, should there be a flu wave and the number of corona infections rise again.

This is a program approved by the Prime Minister in 2013, in order to focus on developing synchronously the infrastructure system, human resources and intermediary institutions of the science and technology market in order to improve operational efficiency. application and technology transfer; promote supply and demand relationships for science and technology products and services. Mr. Pham Duc Nghiem – Deputy Director of the Department of Market Development and Science and Technology Enterprises (Ministry of Science and Technology), in charge of Program 2075 – visited the exhibition booth of the research team including Pharmacist Phan Ke Son and Assoc. Dr. Ha Phuong Thu (Institute of Materials Science). This commercialization project is chaired and implemented by the Institute of Materials Science, in collaboration with CVI Cosmetics Pharmaceutical Joint Stock Company with funding from the State Budget and reciprocal funding from enterprises – companies. CVI company for raw materials, machinery and equipment. The close cooperation between scientists and enterprises not only helps the successful research of the project but also transfers the research results into commercial products to the market. However, during the implementation of the project, the Department of Market Development and Science and Technology Enterprises of the Ministry of Science and Technology – the focal unit to implement the 2075 Program – played an important bridging role. , while actively following the project’s tasks, completing the legal environment, improving the efficiency of state management of the S&T market; promote S&T market service activities as well as technology demand and improve technology transfer capacity. Through the 2075 program, with the support of the Department of Market Development and science and technology enterprises, the project has completed the technological process of manufacturing functional foods from three-size nanomaterials and commercializing them. successful technological process as well as functional food products. In addition, the 2075 Program has helped promote the connection between state agencies and agencies, science and technology enterprises, innovative start-ups and intermediaries and thereby improve effective commercialization of technology, contributing to attracting stakeholders to the S&T market.

According to Lieutenant Colonel, Associate Professor, Assoc. Prof. Dr. Chu Van Men, Director of the Center for Clinical Trials and Bioequivalence, Military Medical Academy, phase 3 injected the Nano Covax vaccine to 13,000 people and administered only a single dose group injection. at least 25 mcg and the placebo injection group. Specifically, according to the protocol approved by the Ministry of Health, the first 1,000 trial injectors of the first phase of phase 3, the volunteers are injected with the ratio of “6 people vaccinated, 1 person injected placebo”. The remaining 12,000 people injected according to the ratio “2 people vaccinated, 1 person injected placebo”. It is expected that the first phase of phase 3 will be conducted by the Military Medical Academy and the Pasteur Institute in Ho Chi Minh City with 1,000 volunteers, each with 500 people. Vietnam’s first COVID-19 vaccine tested in phase 3 on humans. Regarding the reason for choosing the dose group of 25 mcg, Assoc. Prof. Dr. Chu Van Men said that testing at 3 dose levels of 25-50-75 mcg showed that the vaccine was safe on volunteers, capable of generating immunity in 3 doses. There was no difference in dose groups. Therefore, the National Ethical Council in Biomedical Research, Ministry of Health decided to only inject 1 optimal dose of 25 mcg at this stage. Phase 3 is implemented in many centers in the country: The North is deployed by the Military Medical Academy as the focal point at Military Medical Hospital 103, in collaboration with the Preventive Medicine Center of Hung Yen province to deploy locally; In the South, the Ho Chi Minh City Pasteur Institute is the focal point to deploy, in collaboration with the Preventive Medicine Centers of Long An and Tien Giang provinces to deploy locally. After the phase 1 and phase 2 trials, the Nano Covax vaccine is judged to be quite safe, so the criteria for recruiting volunteers will be relaxed more than the previous two phases. 13,000 volunteers participating in phase 3, aged 18-75 years old, only need to check their blood count and check for antibodies to the SARS-CoV-2 virus. People who have been exposed to the SARS-CoV-2 virus or already have antibodies will be excluded from the test population. As of June 11, more than 6,500 volunteers have registered to test the Nano Covax vaccine against COVID-19 phase 3. Senior Colonel, Assoc. Prof. Dr. Ho Anh Son, Deputy Director of the Military Medical and Pharmaceutical Research Institute, Military Medical Academy added: “It is expected that by mid-September 2021, after about 42 days of the second injection. In two of the first 1,000 experimental injections, we will summarize the results of the quality assessment to report. If it is favorable, we will submit the dossier and propose the Government, the Ministry of Health, and the National Ethical Council in the study. In parallel with that process, the unit will continue to test the Nano Covax vaccine on 12,000 volunteers to continue to control the experimental injection and evaluate the effectiveness. protective power of vaccines”. During the testing process and after the antibody sample is available, the Military Medical Academy will coordinate with the Nanogen Pharmaceutical Biotechnology Joint Stock Company, the testing units to conduct the assessment of the ability to neutralize the SARS-CoV virus. -2 in the laboratory for existing virus strains to determine the development direction of vaccine research in the coming period. Through discussions with the expert group of Nanogen Pharmaceutical Biotechnology Joint Stock Company, in addition to recombinant protein technology, there are other technologies for research and production of vaccines. Nanogen as well as many Vietnamese scientists are very interested in mRNA technology – which has been of great interest to the world in recent years. This technology has the advantage of reacting very quickly to the disease, quickly getting a vaccine. According to available information, vaccines produced by this technology are very safe for human use. More information about the phase 3 trial, Lieutenant General, Prof. Dr. Do Quyet, Director of the Military Medical Academy, said that this trial phase is designed according to the adaptive design method, continuing to inject the experimental vaccine. trial and placebo group; health assessment at the time of the first injection, the second dose (done on the 28th day), the 35th day and the 42nd day after injection. The Director of the Military Medical Academy expressed confidence in the safety of the Nano Covax vaccine with the results achieved through the previous two testing phases. Specifically, the concentration of SARS-CoV-2 virus antibodies after the phase 2 trial injection showed that the antibody titre increased very high, from tens to hundreds of times. After the second injection, the volunteers had a physical examination (blood test, blood pressure measurement…) once a week to assess the amount of antibodies appearing in the body; then continue to be monitored for 6 months to get information, assess health as well as immunity ability. Up to now, 100% of volunteers who have been vaccinated with Nano Covax vaccine have produced antibodies in the blood. – Phase I (December 2020), the COVID-19 vaccine Nano Covax was administered to 60 volunteers. – Phase II (February 2021) injected over 554 people. From phase 2, the trial was conducted both at the Military Medical Academy and the Medical Center of Ben Luc district – Long An province (by the Pasteur Institute in Ho Chi Minh City).

Illustration. At the meeting of the National Steering Committee for COVID-19 prevention and control on the afternoon of June 11, Deputy Minister of Health Tran Van Thuan informed that the Ministry of Health had officially approved the phase 3 clinical trial of the vaccine. Vietnam’s first COVID-19 room named Nano Covax. According to Deputy Minister Tran Van Thuan, the Ministry of Health has just approved the phase 3 clinical trial of Nano Covax vaccine of Nanogen Company. According to Lieutenant Colonel, Assoc. Dr. Chu Van Men – Director of the Center for Clinical Trials and Bioequivalence, Military Medical Academy, Ministry of National Defense, phase 3 injected the Nano Covax vaccine to 13,000 people and injected only a single dose group. 25 mcg and placebo injection group (with a ratio of “6 people vaccinated to 1 person injecting placebo” according to the design approved by the Ministry of Health). As for the reason for choosing the 25 mcg dose group, Assoc. Prof. Dr. Chu Van Men said that when the phase 2 trial showed that, the 3 dose levels of 25-50-75 mcg had equivalent safety and immunogenicity. undifferentiated. Therefore, in order to ensure the safety and increase the effectiveness of the number of doses of vaccine production, the National Ethical Council in Biomedical Research, the Ministry of Health decided to inject only 1 optimal dose of 25 mcg at the initial stage. this. Minister of Health Nguyen Thanh Long and Minister of National Defense Phan Van Giang asked and encouraged volunteers to test the vaccine against COVID-19 Nano Covax. Photo: PV. On June 11, the Military Medical Academy said that this unit has started to deploy the phase 3 trial injection of the COVID-19 Nano Covax vaccine for the first 19 volunteers. On the day of injection for 200 people, divided into 2 groups. Accordingly, one group injected the Nano Covax vaccine with a dose of 25mcg, the other group injected a placebo with aluminum excipients. Military medical students will inject 1,000 volunteers in the first time. According to the research outline, phase 3 will test on about 13,000 volunteers in many provinces such as Hanoi, Hung Yen, Long An, Tien Giang… At the Military Medical Academy, there are currently more than 7,000 volunteers registered to participate in the trial, of which more than 600 people have been screened and are eligible to participate. Besides, IVAC’s Covivac vaccine is also preparing to complete phase 1 trial and enter phase 2 in July 2021. Regarding the subjects of vaccination, according to Deputy Minister Tran Van Thuan, in addition to the priority subjects for COVID-19 vaccination under Resolution 21, the Ministry of Health has added workers in industrial zones and will propose more subjects working in establishments dealing in essential goods.

All of these vaccines are allocated to priority subjects according to Resolution 21 and localities with industrial parks. Vaccines for COVID-19. Photo: Times of India. In addition, from now until the end of the third quarter, Vietnam will also receive an additional 2 million doses of AstraZeneca’s vaccine ordered by the Ministry of Health through VNVC. In the third quarter, information from the pharmaceutical company Pfizer said that 3 million doses of vaccine can be shipped to Vietnam, the rest will be concentrated in the fourth quarter. However, the specific time and quantity may change due to dependents. of the world situation. According to Professor Dang Duc Anh, the COVID-19 vaccine has a very short shelf life, only about 6 months. Meanwhile, the time from the production facility to Vietnam takes about 2 months, so it only takes 3-4 months to deploy the injection. In particular, Pfizer’s vaccines must be stored at deep minus temperatures (-70 degrees Celsius). If the temperature is 2-8 degrees Celsius, this vaccine is only used for one month. Therefore, in the coming time, the Ministry of Health will coordinate with units of the Ministry of National Defense across the country to ensure the preservation and transportation of vaccines to the injection point in the shortest time. Up to this point, Vietnam has urgently approved four COVID-19 vaccines: AstraZeneca, Sputnik V, Sinopharm and Pfizer. Vietnam aims to have 150 million doses of COVID-19 vaccine this year for at least 70-80% of the population, to form herd immunity. However, only 4 batches of AstraZeneca’s vaccine have arrived in Vietnam with a total of nearly 2.9 million doses. Earlier, Minister of Health Nguyen Thanh Long stated that Vietnam is facing the 4th wave of COVID-19 epidemic with the Delta variant of SARS-CoV-2 capable of spreading quickly and widely. The Vietnamese government is drastically directing epidemic prevention and control measures to soon stabilize the situation. One of Vietnam’s priorities in COVID-19 prevention is to have a COVID-19 vaccine early and to implement broader vaccination coverage for the population. Therefore, in parallel with efforts to find, negotiate and discuss with partners and vaccine manufacturers to bring vaccines to Vietnam, the Ministry of Health and related ministries and branches also focus on developing domestic vaccines to gradually ensure vaccine autonomy. At the same time, Vietnam also participates in COVAX’s global vaccine supply mechanism.

In the statement, the WHO’s independent expert panel recommended that Sinovac be given to adults over 18 years of age, with a second dose initiated every 2-4 weeks. There is no age limit for this vaccine, as data shows it is likely to protect older adults. This is the second Chinese vaccine approved by the WHO for emergency use – after the Sinopharm vaccine approved in early May. Covid-19 vaccine box manufactured by Sinovac pharmaceutical company. Photo: Anadolu Agency. A third Chinese vaccine, manufactured by CanSino Biologics, has submitted clinical trial data, but WHO has not scheduled a review. Sinovac said it had delivered more than 600 million doses of the vaccine at home and abroad as of the end of May, of which more than 430 million had been administered. In addition, China has deployed hundreds of millions of doses of its own vaccines – including Sinopharm and Sinovac – to many countries, especially in Latin America, Asia, and Africa. Many of these countries have difficulty finding a vaccine developed by the West.

Trang said that at first she found it difficult to learn, so it was easy to get discouraged, many ingredients had to be memorized. But the more I learn 2K2, the more I find this industry useful, every time I have a disease, I know why, how to treat it, what medicine to take, what to do or not to do. Therefore, studying Pharmacy has been of great help to herself and her family, so Trang told herself not to falter. Moreover, it motivated Trang to find a more scientific way of learning so as not to be confused in the knowledge of the industry. As a health lover, conscious of eating scientifically and exercising regularly, and knowledgeable about the pharmaceutical industry, Trang keeps a “shape” that many young people dream of. Not only keeping herself a healthy and beautiful girl from her charisma, but Trang is always ready to share instructions for those of you who don’t really know how to take care of yourself. “I often advise people to eat all four groups of nutrients, not skipping any group and not even starving. Don’t let weight loss pills fool the eye. If you want to lose weight, you should calculate the calories you take in and the calories you burn. Daily gentle exercise is very important, everyone can choose Yoga to help their body be more flexible “- Trang said. It is from the fact that she has witnessed many male friends or has a habit of body shaming women that Trang feels quite disgruntled. That is also the reason why Trang wishes to share and help people become more confident, proving that nothing is impossible to solve. “People should not be afraid of doing wrong or being laughed at by others, because everyone has their own flaws and their own beauty,” Trang said. In the future, Thao Trang wishes to study Pharmacy well so that she can move back to Hanoi to live and work for her family and find opportunities to help people who are being dominated by body shaming, helping them have a different perspective and life live better.

The effectiveness of the vaccine so far cannot be denied. The United States, although not widely open to the world, has dragged down its number of infections in just the past few months. Based on data collected during vaccination, the US Centers for Disease Control and Prevention (CDC) has announced that the effectiveness of major vaccines such as Pfizer or Moderna is up to 95%. even with new variants. This makes it possible for American people to comfortably go out without having to wear a mask, while the US Government considers lifting the ban on international movement. Similar effects have also been observed in Israel and Europe, where vaccination rates have reached 60% – that is, herd immunity can be generated. The “miracle” that brought life back to its normal rhythm seemed to be at last. Small doses of vaccines are becoming the hope of the whole world in the fight against COVID. However, at the same time, a new wave of infections broke out in India. Since mid-April, an additional 5 million new infections have been recorded in this South Asian country. The number of new infections continuously reached approximately 300 thousand cases per day, of which several thousand people died from the disease every day. The epidemic tsunami was so great that it knocked down India’s health system in just a few days, a real disaster. It is hard to believe, until the 4th wave of infections broke out, India was the country with the 3rd highest number of COVID vaccines in the world and was a hope for the whole world thanks to its huge vaccine supply. However, the number of nearly 100 million doses of vaccine administered out of a population of 1.3 billion is still too small to achieve a state of herd immunity, as epidemiologists hope. The government’s subjectivity then caused the contagion to erupt violently at a time when major religious ceremonies were held in this huge country. Consequences for the people and country of India so far have not been fully enumerated, but more dangerous, it is slowing down the whole world’s efforts to open up, when the supply of vaccines is mainly for people. Poor countries under the WHO COVAX program have stalled, because India has urgently applied a ban on vaccine exports to save itself first. In addition, the fourth wave of infections has also begun to spread around the world, from Asia, Africa to South America, where vaccination rates are far from reaching the thresholds that can create health problems. herd immunity. No one can stand alone The Indians cannot be blamed for the decision to close the vaccine supply at this time, because indeed the images and death figures every day in the newspaper make anyone horrified. Before that, it was India that took the lead in efforts to help the poorer people to have access to 66 million doses of vaccine in the first quarter of this year. Now that responsibility needs to be reinforced. In contrast, the US, UK, EU and Israel have come up with plans to reopen. Learning from India’s mistakes, these countries have been more cautious. From May 23, tourists can return to Israel and the EU if they comply with the mandatory conditions. The problem is that if that rule is followed, there are not many qualified guests. Because, in addition to having received the correct vaccines recognized by the EU, that traveler must also be from countries with the number of new infections below 25 cases per 100,000 inhabitants in the previous 14 days. Those are the countries that the EU calls “safe”. However, there are currently only 7 countries outside the EU that meet this criterion, such as Israel, Australia, New Zealand, Singapore, etc., but that list does not include the US. That is, the invitation to travel to Europe is still only “give it up”. The door was opened but very few people could enter. The “Indian lesson” makes us realize that vaccination speed will determine the success or failure of a global vaccine strategy. As the United States and Israel quickly immunized the majority of the population, the SARS-CoV-2 virus was easily defeated. But, the drip vaccination rate will not be enough to create herd immunity and even allow the virus to mutate against the same old vaccines. Finding a vaccine for the poor is never easy. The fourth wave of contagion, therefore, has broken out in these very countries, with new variants that are more dangerous and could completely hit countries that already have high vaccination rates. Therefore, in order to solve the problem at the root, it is the rich countries that will have to take the lead in a new effort, to rescue the worldwide shortage of vaccines. Conflicts of interest A group of 13 countries has been identified by the World Bank (WB) as holding control and global distribution of vaccines. Among these, there are of course big countries like India, China, Russia, the G7 group and a few other European countries like Austria, Switzerland, Sweden. They are collectively known with a beautiful name, “The Club of Vaccine Producing Countries”. This club controls up to 88% of vaccines and 91% of vaccine companies in the world. Among them, mainly developed countries in the West. It is not surprising that the US and EU have achieved the highest vaccination rates in the world in a short time. Despite earlier claims to share vaccines with the world, “vaccine nationalism” prevailed initially. They have even started to have an oversupply of vaccine in their inventory after the last 3 months of intense vaccination. Therefore, when making the call for the rescue of vaccines in the world, both WHO and the United Nations are directly targeting this group of countries. Now it’s time for them to extend their hand to play the role of “saving the world”. However, this is also the time when the controversy broke out the most. The US has announced that it will deliver 70 million doses of its vaccine to developing countries between now and July. The EU will also contribute back to the COVAX program, after a temporary withdrawal to keep the vaccine for itself. But, even so, it’s still not enough. Because the most advanced vaccines being used by the US and EU require extremely complex preservation technologies that are not easy for poor or developing countries to meet. In Africa, hundreds of thousands of doses of vaccines have been destroyed, even though they still have their expiry date, because they cannot guarantee the storage conditions on the way to users. This situation may be even more serious, when the number of vaccines from the EU and the US is brought in in large numbers in the near future. And the cost of high-end vaccines like Pfizer or Moderna is never cheap, when Pfizer – BioNtech or Moderna apply the most advanced technologies that not even Russia or China have access to. A new call has been made, for rich countries to share vaccine copyrights with poor countries, in order to create a vaccine that suits them. However, advanced genetic technologies are copyrighted by major pharmaceutical companies, where they want to hold the secret not only for this COVID vaccine. As a result, the controversy has shifted from the states to the people of the vaccine-hungry poor countries, with the wealthy owners of the big pharmaceutical companies. Loss of motivation to research to find new products is the reason that big pharmaceutical companies rely on to protect their patents. Meanwhile, inequality in vaccine distribution has serious consequences for the lives of hundreds of millions of other people. Still, it wasn’t easy for those wealthy owners to give in. Therefore, before relying on the “kindness” of pharmaceutical companies, the most concrete thing that rich countries can do is probably just to try to fill this inequality by giving poor countries the opportunity to do so. access to their starting surplus vaccine resources. Saving people is actually saving yourself.
Tu Uyen

From the beginning of the fourth epidemic until now, the Department of Science, Technology and Training (Ministry of Health) has also directed health human resource training institutions nationwide to prepare and be ready to mobilize staff and lecturers. , students and students volunteered to participate in the prevention and control of Covid-19 epidemic. On May 27, the Ministry of Health mobilized staff, lecturers, trainees and students to volunteer to support the provinces of Bac Giang and Bac Ninh with the number of volunteers supporting 375 people. In which, Hanoi Medical University has 120 people, Thai Nguyen University of Medicine and Pharmacy has 104 people, Vietnam Academy of Traditional Medicine has 36 people, Hai Phong University of Medicine and Pharmacy has 65 people, University Nursing Nam Dinh has 50 people. The delegations were present in Bac Giang province today. Particularly, the delegation of Nam Dinh University of Nursing will be present tomorrow (May 28). Currently, 1,976 officials and students from 15 universities and colleges of medicine and pharmacy are participating in epidemic prevention and control activities in 13 provinces and cities: Bac Ninh, Bac Giang, Hanoi, and Ho Chi Minh City. Minh, Hai Phong, Nam Dinh, Thai Binh, Can Tho, Da Nang, Quang Nam, Binh Dinh, Thua Thien – Hue, Dien Bien, K Hospital and assist the Department of Preventive Medicine (Ministry of Health) in implementing Currently monitoring, evaluating and reporting epidemic developments by provinces. As of 12 p.m. on May 27, 34 training institutions have informed the Department of Science, Technology and Training (Ministry of Health) the number of officials, lecturers, students and students who are willing to participate in supporting the department. , against the Covid-19 epidemic when mobilized was 23,888 people. Step 1: Visit https://www.bluezone.gov.vn or download directly at App Store or CH Play. Step 2: Once downloaded, the application will ask for permission to use Bluetooth to record contact with other Bluezone installed users. If Bluetooth is not open, drag the status bar and turn on Bluetooth; or go to Settings, select Bluetooth and turn it on. Step 3: Once the installation is done, click Scan Around. If someone near you less than 2m has used Bluezone, the application will automatically identify these users and put them in the contact list.

And then, Salk appeared as a savior with a vaccine that he tested directly on himself and family members. Just two years after Salk’s vaccine became widely available, the number of polio cases has dropped to just one in ten. Salk may have made a fortune from his invention but instead, he donated it to humanity, because in his opinion it is the intellectual property of the common people, like the sun, no one has exclusive rights to own the sun. . Rolling Stone magazine painting depicts pharmaceutical companies as a large vulture profiting from COVID-19. Comparing vaccines to the sun is a linguistic error on Salk’s part, because the sun is a product of the universe (or god), and vaccines are not. In the 18th century, the doctor Edward Jenner made a boy immune to smallpox by taking fluid from the wound of a woman who had had cowpox (a cowpox disease) and injected him, from That was the first time a vaccine was created. While injecting wound fluid from one person into another does not qualify Jenner for any patents, most vaccines today are much more complicated and require a team of experts to spend months, even even years of research and testing. In other words, vaccines are a human invention. However, Salk’s comparison only implies his belief that, in essence, the purpose of science is to serve humanity unconditionally. Salk’s story deserves a repeat at a time when the Biden government has a desire to remove intellectual property rights over vaccines so that poor countries can also access this knowledge and save lives. its citizens. But, many European countries objected. Even the leaders of giant pharmaceutical corporations also objected. They say the move will stifle and destroy the motivation to improve vaccines for businesses and scientists working for them. And they are absolutely correct. Profit is a reward for those who deserve it. Frederick Winslow Taylor, known as the father of scientific management, at the beginning of the 20th century put forward a theory that greatly influenced production systems around the world. Its basic is: money is the motivator. Although there have been many theories with ideas that go against it, after all, it is not Cuba Gooding, Jr. got a supporting role in the movie “Jerry McGuire” thanks to a scene in the phone shouting to the male lead Tom Cruise: “Show me my money!” or what? We all love that line and it’s classic because it’s so real, so raw, so true. Money and profits are very important. Drug companies cannot be told to sacrifice their profits when, as the New York Times puts it, “pharmaceutical corporations are addicted to huge profits”. Calculating from 2000-2018, the world’s 35 largest pharmaceutical corporations alone generated $11.5 trillion in revenue and a net profit of $8.6 trillion. The pharmaceutical industry’s net profit margin is higher than any other industry. And it’s been like that since the mid-1950s. In “Pharmaceuticals: Greed, Lies, and Poisoning America,” author and investigative journalist Gerald Posner recounts the stories of the early days of some of the biggest pharmaceutical giants and how they built their empire. As a story happened in 1990, German company Bayer released a “divine” pain reliever aspirin with a name inspired by “hero” in German. They promote it as a treatment for a dozen diseases: colds, coughs, asthma, epilepsy, stomach cancer, multiple sclerosis, bipolar disorder. They also claim that it is safe for children. Are you curious to know what kind of medicine that cures all diseases is no different from the drugs advertised by quacks on Facebook? Please, that drug is… heroin. Or another story during World War II, when the advent of antibiotics helped pharmaceutical companies to get rid of the reputation of specializing in producing addictive drugs to become pioneers in saving lives, these companies immediately applied for a patent for a series of antibiotics that could be used for many health problems and created a frenzy for doctors to prescribe antibiotics for 90% of the cases when patients came to see them, even though they did not practice them. the need for antibiotics to cure the disease. The disastrous consequences of the antibiotic craze are now starting to become more pronounced. But, that’s okay, for the pharmaceutical companies, it’s important that they make a profit. Profit may not be Salk’s driving force, but it is the driving force of pharmaceutical companies. But today’s world is also much more complicated than before, it is difficult for single individuals to create a specific power because the world is operated by corporations with centipedes growing all over the globe. We can’t tell tigers not to eat meat, that’s their nature and we can’t ask big pharmaceutical companies to be as “humane” as Salk. Illustration of “polio soldier” Jonas Salk on the cover of Time magazine. Pharmaceutical companies also argue that removing patents with COVID-19 vaccines will set a bad precedent and cause many other inventions to be removed in the future. But, they never questioned the fact that, constantly applying for patents also makes everything patentable, even the human genes – which are inherently natural – become obsolete. become someone’s intellectual property. In 2012, a case caused a stir when the biotech company Myriad Genetics was sued for holding a patent for two genes related to ovarian and breast cancer, BRCA1 and BRCA2. They weren’t the only ones at the time who possessed the gene. About 20% of the human genome was then owned by a corporation or a scientist. The petitioner argued that Myriad could not possess genes just as one could not own gold. But, Myriad compared the gene to a baseball bat, although it has natural materials, but cutting out which gene segment is a scientific choice. After many long years, finally Myriad lost the patent but let’s imagine for many years, the gene in our body belongs to someone’s intellectual property, which is very absurd but still blatantly exists. . And after all, does removing some research patents hurt scientists’ motivation to do research? Roentgen refused to apply for a patent for X-rays and what was his reason? His excuse was that it would limit the progress of this discovery! And instead of damaging the motivation for research, his later successors in the field of radioactivity were Marie Curie and Pierre Curie, who were honored not only for their discovery of radium, nor for them. not only because they found radium at the expense of their health, but also because they found radium. Traded his health but gave it away to the world for nothing. You could say Roentgen was already a millionaire by inheriting the family fortune so he didn’t need more money but Marie Curie was different, she was later unable to buy 1 gram of radium, the element she discovered herself. But she never regretted it. Marie Curie said: “Radium is not meant to enrich anyone. Radium is an element and it belongs to man.” Roentgen or Marie Curie are still single individuals. We have the right to hope in the noble hearts of single individuals, but we should not hope in the kindness of tigers, should not hope in the noble hearts of corporations.

Hoa Binh said, with the expanded project scope, the Board of Directors of the Company also approved to increase the total investment capital for the HBIC project from 750 billion VND to 900 billion VND, an increase of 20%. Accordingly, Hoa Binh assigned Mr. Le Viet Hai, Chairman of the Board of Directors to be the legal representative and Chairman of the Members’ Council of HBIC One Member Limited Liability Company. Mr. Hai was able to actively organize and adjust the company’s organizational model in order to improve production and business efficiency during the implementation process. About Hoa Binh Innovation Center (HBIC), this project has been awarded the investment certificate since February 2016. The project will focus on research and development in 6 areas including new material technology, information technology, biotechnology – medicine, technical development of construction technology and automated industry on the ground floor. about 2.5 hectares. HBC’s goal will be to build a center that is the leading place for incubators, start-ups, R&D, innovation and high-tech transfer in the country, and in Southeast Asia.

According to the news agency DW The final decision on whether or not to give up the copyright for the COVID-19 vaccine will be decided by the 164-member World Trade Organization (WTO). Of these, more than 100 countries have supported negotiations towards the abolition of measures to protect intellectual property rights with the COVID-19 vaccine. However, as long as a country disagrees, the WTO cannot approve this proposal. However, there are still countries that oppose the US move. Press conference on this issue on May 6, a spokesman for the German government warned that this would make pharmaceutical companies and biotech companies lose motivation to research and develop vaccines, negatively impacting. the entire vaccine industry in general. Therefore “the protection of intellectual property is a resource for creativity and must be maintained in the future”. The waiver of the vaccine license does not help much in the goal of increasing world vaccination coverage. The reason, “the factors that limit the number of vaccines vaccinated are production capacity and quality standards, not the copyright story”. Protect effort and gi Oh degree ng l Ugh c research According to radio CNN In the current context, giving up intellectual property rights with vaccines is a very complicated problem. A vaccine that has been successfully researched and developed is a collection of a series of different ingredients and materials and each ingredient and ingredient is copyrighted by at least one company or researcher. wisdom. For example, inside the vaccine company Pfizer (USA) and Biotechnology Company BioNTech (Germany) produces 280 ingredients and materials are licensed from many parties from 19 countries. Once a waiver scenario occurs, anyone can freely access and use the ingredients and ingredients in this vaccine – causing significant damage to Pfizer, BioNTech and others. holding the copyrights of those ingredients and materials. Medical staff in the capital Berlin (Germany) prepare the vials of vaccines to be vaccinated in April. Photo: DW “A single dose of vaccine contains all intellectual property from licensing agreements, copyrights, industrial designs to trade secret protection laws, patent secrets. If the copyright for the COVID-19 vaccine is abandoned, how can this be enforced? ” – Intellectual property rights expert Achal Prabhala of the Shuttleworth Foundation (South Africa) analyzed. Mr. Prabhala also affirmed that intellectual copyright is the backbone of the entire pharmaceutical and medical industry because it is difficult and time-consuming to research and create a product that is safe to use in humans. The recognition and protection of copyright is a way of respecting the efforts of researchers. The risk of technology secrets disclosure Another equally important issue when it comes to vaccine licensing issues is the protection of vaccine technology and formulation. Currently, Pfizer, BioNTech and Moderna (USA) are the pharmaceutical companies and technology companies leading the use of new generation mRNA technology to significantly increase the effectiveness of vaccines. This technology is also evaluated to be highly applicable not only in the prevention of COVID-19 but also in other diseases in the future. Meanwhile, pharmaceutical companies in Russia or China have not fully applied this technology; Vaccines that these countries produce and put into use do not have mRNA technology, so the effectiveness level is also somewhat not as high. “Pfizer and Moderna took years of research to develop these vaccines. China and Russia and other countries both want to access it. Their goal is to possess the underlying technology to make vaccines not only to prevent COVID-19 but also for other diseases, ”said former US Ambassador to China Gary Locke. Reuters . In the event that the vaccine rights are abandoned, Beijing will likely force the above-mentioned pharmaceutical firms to hand over the technology if they want to operate in the Chinese market. On the other hand, Beijing may also ask other companies to generate income for such information without fear of being criticized for stealing foreign company secrets. If pharmaceutical companies refuse to provide information, they will face many legal consequences. Remember, intellectual property rights have been a big question between the US and China for many years now, and has been one of the main reasons for the outbreak of the US-China trade war in 2018. • EU completed a contract to buy 1.8 billion vaccine money Associated Reuters May 10 quoted Mr. Thierry Breton – Commissioner in charge of industry and domestic markets the European Union (EU) said that this bloc will not continue to buy vaccine COVID-19 by the pharmaceutical company AstraZeneca (UK-Switzerland). Swedish) production. The reason AstraZeneca has not met its commitment to supply vaccines to the EU. By the end of the first quarter of 2021, the EU received only 67 million doses of vaccine from AstraZeneca, although the initial target was 300 million doses. It is expected that in the second quarter, the EU will receive an additional 250 million doses. The remaining 280 million doses will be delivered to the EU by AstraZeneca during the last six months of 2021. In addition to legal disputes with the EU, AstraZeneca’s vaccine reputation has also deteriorated due to information related to adverse reactions. Some European countries such as Denmark have stopped using AstraZeneca’s vaccine, while in most other countries in the region, this vaccine is only used for people over 55 years old. After discontinuing the contract with AstraZeneca, the EU plans to order more vaccines using mRNA technology such as Pfizer / BioNTech or Moderna. In fact, European Commission President Ursula von der Leyen said over the weekend that the EU has officially completed a contract to buy up to 1.8 billion doses of Pfizer / BioNTech vaccine over the next two years.

Developed by a small group of the most talented vaccine scientists on the planet and industrially produced by the leading pharmaceutical giant with many prestigious certifications, Vaxzevria (the official new name for the Oxford / AstraZeneca vaccine in Europe) has been making hot headlines for many months. But not the kind that manufacturers have high expectations for. Months later, the manufacturer was not only caught in the political conflict between the EU and the UK, but also by the increasingly complicated conflicts. As a result, many governments around the world have recovered parts of Vaxzevria (some countries call it Covishield). Even when the third wave of outbreaks broke out in Germany and the EU, followed by a number of people claiming they wanted to be injected with any vaccine except for AstraZeneca. What’s wrong with that? The following survey by reporters Der Spiegel has reorganized the stories surrounding AstraZeneca in recent weeks to envision the disaster facing not only the pharmaceutical company but also many other countries. British Prime Minister Boris Johnson (center) in an AstraZeneca vaccine factory. The Story of AstraZeneca The story of Vaxzevria begins at the Faculty of Medicine Nuffield, a research center on the eastern edge of the University of Oxford city. On January 30, 2020, a group of prominent researchers gathered there, just one day before the Brexit event and one day before the first two COVID-19 infections were announced in the UK, to be exact. is in York, 300 km away. For weeks, researchers continuously watched news about an outbreak of a virus in Wuhan (China), in a restless mood. As Prime Minister Boris Johnson’s governmental capacities are fully focused on leaving the EU, scientists at Oxford discuss how they can do to save the world. Among those present that day was Sarah Gilbert (a mediocre professor at the Jenner Institute) who was experimenting with yeast in a brewing research laboratory before becoming a world-renowned vaccine expert. Ms. Gilbert has researched on vaccines against malaria, Ebola and MERS, and is also preparing vaccines for “Disease X” – the next major pandemic that scientists are working on. . Ms. Gilbert (who has been studying the SARS-CoV-2 genetic code for weeks) has surprised colleagues by asserting that a vaccine will soon be available. At the time, Ms. Gilbert was working on phase 2 of Phase 1 clinical trials of a vaccine against MERS (Middle East Respiratory Syndrome) caused by a virus in the coronavirus family. By March 2020, Oxford experts have completed the first batch of new vaccines used to destroy SARS-CoV-2. The swine clinical trials in Surrey County have shown promising results. But obviously a huge amount of vaccine is needed, as much as possible. So Oxford started looking for partners in the pharmaceutical industry, and the first choice was pharmaceutical giant Merck (USA). But because Mr. Donald Trump’s “America First” thought made the British hesitant when working with Americans and the deal with Merck broke down. Speaking later on LBC radio, UK Health Minister Matt Hancock posted on the forum explaining that he did not want to enter into a contract that would allow the first batch of Oxford vaccine to be given to other countries. In April 2020, AstraZeneca’s Anglo-Swedish joint idea was born. Mr. Pascal Soriot, CEO of AstraZeneca. Pascal Soriot and AstraZeneca When Pascal Soriot took over AstraZeneca in 2012, the company was at a bottom: stock prices plummeted, and the risk of losing its drug patents. Soriot is deep into AstraZeneca: instead of reducing costs, he invested in product development, bought more companies, and resisted Pfizer’s American acquisitions. Today, AstraZeneca is the 2nd largest company in the UK. At the age of 61, Mr. Soriot soon learned to build himself. Raised up in the Paris suburbs and his father passed away when his son Soriot turned 20 years old. Soriot then enrolled in the Paris Business School (HEC) and entered the pharmaceutical industry. In 2020, AstraZeneca’s CEO Soriot announced that his company was planning to tackle a very difficult public health problem: producing vaccines against COVID-19. AstraZeneca initially announced a partnership with Sarah Gilbert and other Oxford scientists. AstraZeneca plans to export vaccines globally at prices ranging from $ 2 to $ 5, and aims that poor countries will have access to vaccines as quickly and equally as possible. At the same time, Soriot also assured Prime Minister Boris Johnson that would provide the first and exclusive large quantity of vaccine to the UK. However, the AstraZeneca staff said that Soriot was subjective in not considering the possible consequences of failure. Without hesitation, Soriot approaches the vaccine strategy as it does with all of its projects. AstraZeneca is committed to producing 300 million doses of the vaccine for the EU by mid-2021, as well as another 100 million doses for the UK. AstraZeneca is producing Vaxzevria in at least four plants in Europe; Two of them are Oxford Biomedica and Cobra Biologics (both located in the UK); The other two facilities are Thermo Fisher and Halix (located in Belgium and the Netherlands). The four factories are operated by subcontractors, not by AstraZeneca. And at least two of them have had problems right from the start. At first, Thermo Fisher produced fewer vaccines than expected. And Cobra Biologics does not work synchronously. The Dutch health expert, Wilbert Bannenberg, was not surprised by AstraZeneca’s vaccine production glitch when it came to the hundreds of ingredients used in vaccines like Vaxzevria, even with small deviations in the ingredients. The raw material also causes the finished product to be discarded. By the end of 2020, it was clear that AstraZeneca was having difficulty in the contracts it had to make. Soriot is wondering whether to leave the UK or leave the EU. And the owner of Downing Street began to form a specialized vaccine force consisting of famous experts and scientists. Led by biochemist and venture capitalist Kate Bingham, the force not only created multipurpose vaccines for the British, but also built the UK vaccine industry. In other words, the UK offered vaccine developers an offer they could hardly turn down. Gambling customers’ trust Vaxzevria is the third vaccine to be approved in Europe, after BioNTech / Pfizer and Moderna. But by the fall of 2020 it appears that AstraZeneca’s pandemic studies have become inaccurate. For example, about 3,000 test subjects received half an injection for their first phase, and a full dose for the second injection. Both Oxford and AstraZeneca disagreed in the notion that half the dose was an attempt to act. good idea. AstraZeneca has been criticized because it basically ended up calculating the mean of the data for different groups of test subjects. An even bigger problem is the lack of seniors to include in the study. The Standing Committee on Immunization (STIKO) of the Robert Koch Institute (Germany’s center for disease control) initially recommended AstraZeneca only test 18 to 64 years old, and invisibly turned the island. Inoculation in Germany is wrong. With a feeling of discomfort from a congestion in the vaccine supply, and not yet on any scientific basis, but French President Emmanuel Macron has declared the AstraZeneca vaccine “does not budge at all for people over 65” . Since that time, the vaccine has been ranked 2 in every European country except the UK. In the US, the AstraZeneca vaccine has not even been approved even though President Trump ordered 300 million doses required by the end of May 2020. At first it seemed that AstraZeneca was not completely transparent with Americans when covering the truth about A test subject fell ill at an early stage of the trial. But that is not the last malfunction. In March 2021, AstraZeneca announced that its vaccine was 79% effective in preventing symptomatic infections. But US officials believe that the pharmaceutical company’s data is out of date and may falsify the results. In March 2021, news began to circulate threatening to destroy confidence in AstraZeneca. In some countries, people vaccinated with the Vaxzevria vaccine have developed an embolism caused by a blood clot in the brain, also known as sinus venous thrombosis (CSVT). On 29 March 2021, the Paul Ehrlich Institute (German institution of health management) recorded 31 cases of CSV out of 2.7 million vaccinated people in Germany. Most affected young women. 9 people died. Fearful, some countries have now ended contact with AstraZeneca. Until recently, the European Medicines Agency (EUMA) admitted for the first time that there is a link between thrombosis and Vaxzevria, but EUMA still recommends the Vaxzevria vaccine for all age groups. According to a survey, 23% of French people consider Vaxzevria safe, in Germany it is 32%. Norway and Denmark stopped using the vaccine Vaxzevria. Thrombosis and death were also seen in Britain for the first time. Oxford University has suspended a vaccine trial in children. Experts are on the verge of despair. Ms. Nina Gatter (a vaccinator from North Rhine-Westphalia, Germany) criticized AstraZeneca when saying that the company did not properly display concerns from the skeptical psychology of public opinion. In Europe, there has been growing skepticism and has delayed the vaccination campaign. Many were vaccinated later than planned, while others used different vaccines. Consequences affect the chain elsewhere. The Covax initiative is currently heavily dependent on the AstraZeneca vaccine. The consequences of this lack of trust can be seen in South Africa. The government stopped vaccinating people after it discovered a mutation. The slow results of the COVID-19 vaccinations in South Africa, meaning substances created with the hope of saving the world, are now piled up in stock.

People were tested with Nano Covax vaccine phase 2. In phase 2, the volunteers were divided into 4 groups, including groups of injections with doses of 25mcg, 50mcg, 75mcg and placebo. All 3 doses of 25mcg, 50mcg and 75mcg injected to volunteers were immunogenic, of which the 25mcg dose level is considered to be the most effective. The research team will report the results of phase 2 to the Ministry of Health. It is expected that on April 27, it will submit to the National Bio-Medical Research Ethics Council of the Ministry of Health a plan to deploy the clinical trial injection of Nano Covax vaccine phase 3. According to the plan, Nano Covax vaccine in this phase will be tested in large groups, from 10,000 to 15,000 people, starting from May 5-2021. The research team is expected to propose a single test injection dose of 25 mcg. Previously, as reported by the New Hanoi News, Nano Covax was the first Covid-19 vaccine in Vietnam to be injected for clinical trials in humans, researched and developed by Nanogen Technology Joint Stock Company. In phase 2, there were 560 volunteers registered for the trial, expanding the subjects from 18 to over 60 years old, of which, some people had background diseases such as hypertension, dyslipidemia, diabetes, heart disease. 1 degree circuit … not too heavy. The test vaccination of Covid-19 Nano Covax vaccine phase 2 was held at two bridge points: the Military Medical Academy and the Pasteur Institute of Ho Chi Minh City (participating in the study, conducted in Ben Luc district, province. Long An). For objective reasons, there were 4 people who asked to withdraw from the list of experimental injections. As a result, 556 people completed the second phase of Nano Covax vaccine trial. Step 1: Access to https://www.bluezone.gov.vn or directly download at App Store or Play Store. Step 2: Once downloaded, the app will ask for Bluetooth permission to record contact with other Bluezone installed users. If Bluetooth isn’t open, drag the status notification bar and turn on Bluetooth; Or go to Settings, select Bluetooth and turn it on. Step 3: After the installation is complete, click Scan Around. If someone near you less than 2m has used Bluezone, the application will automatically identify these users and put them on the contact list.

Fresh and dried seahorses and sea dragons are available for sale at Ham Ninh market. With fresh seahorses, it costs about 5 to 8 million VND / kg, but if bought retail, a pair of large seahorses cost about 80,000 VND, the smaller pair, about 40,000 VND. With dried seahorses if straight tail (dried while alive) costs 70 thousand VND / fish, while the dried seahorses cost about 40 thousand VND / fish … The market of Ham Ninh fishing village is located right next to the wharf and for those who first come to Phu Quoc will be surprised to see countless fresh seahorses almost all colors brown, black, yellow, pink … all kinds are sold in large pots, small pots, with oxygen tubing. In the provinces bordering the western waters of the country, Phu Quoc is considered the largest natural seahorse beak. January to April each year is the breeding season of seahorses when they find rock caves, dead coral reefs … to mate. This was also the time when Phu Quoc fishermen caught the most seahorses and sold them crowdedly in Ham Ninh market. In addition to customers who buy for self-treatment and processing, many vendors at the “miracle” market are willing to soak for customers with “miracles” … … from cleaning seahorses and sea dragons to selling both. white wines and bottles or jugs for soaking. According to Ut Map, who has sold seahorses in Ham Ninh for more than ten years, with seahorses, saliva works best, second is the eyes. When soaking in alcohol, fresh seahorses will produce saliva, so the effect is better than dried ones, so if soaking 10 fresh seahorses, with dried seahorses to soak up to 20. Seahorses here have two types, spiny type and non-spiny type. The spiny-free type is purchased faster by the middlemen because the wine is less fishy when soaked like the spiny fish. Because of the use of seahorses for the health of men passed from each other, Ham Ninh is considered to be a place that specializes in selling all kinds of “preventive medicine”. In addition to seahorses, also known as walruses, there are sea dragons, which are similar in use to seahorses, which are widely sold in dry food stalls. Along with seahorses, many visitors are overwhelmed by another kind of “miracle” that is probably only available in the “miracle” market, which is seal seal, sea cow seal is hung or sold right on the front plastic trays store. Another kind of miracle that the gentlemen are looking for is sea cucumber, but in Phu Quoc it is quite rare, but at the Ham Ninh market it is still present. Although it is a natural seahorse beak, but in Phu Quoc this very cute animal is being caught in the way of salvation and destruction due to the large purchasing power of tourists. According to incomplete statistics, each year about 1 million seahorses are caught in the waters of Phu Quoc.

Louis Vuitton bags: Although the beauty has many bags, this compact handbag is still the choice she likes the most because although it is “small but has a martial”, it can hold “the whole world” of Lam Vy Da. Phone: Whenever she is away from home, she will often call her husband and children to ask questions, so the phone is an indispensable item in a beauty’s bag. Lam Vy Da always chooses for herself the most convenient things, so she combines a case that can hold all kinds of credit cards, convenient for all activities in life. Wired headphones: The beauty said, she used to buy many expensive wireless headphones, but she is an forgetful person, so she often loses it. Therefore, the actress came up with an effective countermeasure, which is to use wired headphones, while saving and not dropping. Medicine: Lam Vy Da confided a few years ago while filming a sitcom she was stunned and nearly fainted. After being admitted to the hospital, the doctor’s words shocked her: if you delay a little, the chance of Lin Vy Da having a stroke is very high. Since then, she has been paying more attention to her health, with a plethora of medicines and supplementary products in her bag always in her bag to ensure her health is always in the safe circle. Eyelid stickers and stickers: The secret to Lam Vy Da transforming from one eyelid to 2 glittery eyelids is to use eyelid stickers. The beauty said no to beauty editing because she felt satisfied with herself, and a part of Lam Vy Da’s husband loved her wife’s natural beauty. Lip mask: During filming, the actress needs to make up and apply lipstick a lot, so her lips are prone to dryness and peeling. Lam Vy Da often has a habit of peeling her lips, causing her lips to bleed, so she always has to keep this savior ready to keep her lips soft. Perfume for hair: Must always change the shape to suit many different roles, hair needs to use heat regularly to style, so it is easy to pick up odors. Adding perfume to her hair is the secret to her confidence in any situation. Posts: Bao Tran